Mark L. Steinberg

4.4k total citations · 2 hit papers
51 papers, 3.4k citations indexed

About

Mark L. Steinberg is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Mark L. Steinberg has authored 51 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Genetics and 16 papers in Cell Biology. Recurrent topics in Mark L. Steinberg's work include Skin and Cellular Biology Research (14 papers), Virus-based gene therapy research (10 papers) and Estrogen and related hormone effects (7 papers). Mark L. Steinberg is often cited by papers focused on Skin and Cellular Biology Research (14 papers), Virus-based gene therapy research (10 papers) and Estrogen and related hormone effects (7 papers). Mark L. Steinberg collaborates with scholars based in United States, United Kingdom and Japan. Mark L. Steinberg's co-authors include Alan Webster, Aman U. Buzdar, Vittorio Defendi, Mia von Euler, A Mangalik, Michaël Pollak, William N. Harwin, Jean‐Marc Nabholtz, G. Burton and L. Mauriac and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Mark L. Steinberg

51 papers receiving 3.2k citations

Hit Papers

Anastrozole Is Superior to Tamoxifen as First-Line Therap... 2000 2026 2008 2017 2000 2000 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
    2000 738 citations Aman U. Buzdar, Mark L. Steinberg et al. Journal of Clinical Oncology profile →
  2. Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
    2000 606 citations Jacques Bonneterre, Beat Thürlimann et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark L. Steinberg United States 22 2.0k 1.5k 1.4k 783 720 51 3.4k
Björn Erikstein Norway 24 968 0.5× 1.3k 0.9× 702 0.5× 483 0.6× 859 1.2× 47 2.7k
Pascal Pujol France 27 1.6k 0.8× 1.3k 0.9× 999 0.7× 250 0.3× 1.2k 1.7× 99 3.5k
Cezary Cybulski Poland 34 2.0k 1.0× 1.5k 1.0× 1.4k 1.0× 435 0.6× 1.9k 2.6× 182 4.6k
Laura P. Stabile United States 34 722 0.4× 1.8k 1.2× 504 0.4× 1.3k 1.7× 1.4k 1.9× 88 3.4k
S. M. Lippman United States 20 727 0.4× 892 0.6× 487 0.3× 511 0.7× 1.8k 2.5× 48 3.2k
Isaiah W. Dimery United States 29 949 0.5× 2.2k 1.4× 707 0.5× 1.3k 1.6× 1.7k 2.3× 68 4.6k
Haruo Sugano Japan 29 410 0.2× 789 0.5× 540 0.4× 501 0.6× 1.0k 1.4× 119 3.0k
Marsha L. Frazier United States 39 666 0.3× 1.7k 1.1× 1.4k 1.0× 337 0.4× 2.6k 3.6× 120 4.9k
Frej Stenbäck Finland 27 328 0.2× 737 0.5× 525 0.4× 228 0.3× 1.1k 1.5× 149 2.8k
Regina S. Whitaker United States 34 483 0.2× 1.7k 1.1× 877 0.6× 263 0.3× 2.2k 3.0× 72 4.3k

Countries citing papers authored by Mark L. Steinberg

Since Specialization
Citations

This map shows the geographic impact of Mark L. Steinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Steinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Steinberg more than expected).

Fields of papers citing papers by Mark L. Steinberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Steinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Steinberg. The network helps show where Mark L. Steinberg may publish in the future.

Co-authorship network of co-authors of Mark L. Steinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Steinberg. A scholar is included among the top collaborators of Mark L. Steinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Steinberg. Mark L. Steinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansson, Susanne, Jessica Read, Stuart Oliver, et al.. (2014). Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine. Clinical Pharmacokinetics. 53(9). 837–847. 52 indexed citations
2.
3.
Steinberg, Mark L., et al.. (2008). Patterns of Persistent DNA Damage Associated with Sun Exposure and the Glutathione S‐transferase M1 Genotype in Melanoma Patients. Photochemistry and Photobiology. 85(1). 379–386. 13 indexed citations
4.
Hubbard, Karen, Mark L. Steinberg, Helene Z. Hill, & Irene Orlow. (2008). Mitochondrial DNA deletions in skin from melanoma patients.. PubMed. 18(2 Suppl 2). S2–38. 9 indexed citations
5.
Hwang, Bor‐Jang, et al.. (2006). Induction of cyclin D1 by submicromolar concentrations of arsenite in human epidermal keratinocytes. Toxicology and Applied Pharmacology. 217(2). 161–167. 24 indexed citations
6.
7.
Hwang, Bor‐Jang, et al.. (2005). Modulation of sulfur mustard induced cell death in human epidermal keratinocytes using IL‐10 and TNF‐α. Journal of Biochemical and Molecular Toxicology. 19(4). 213–225. 13 indexed citations
8.
Bonneterre, J., Aman U. Buzdar, John F. R. Robertson, et al.. (2001). Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer. 92(9). 2247–2258. 437 indexed citations
9.
Bonneterre, Jacques, Beat Thürlimann, J.F.R. Robertson, et al.. (2000). Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study. Journal of Clinical Oncology. 18(22). 3748–3757. 606 indexed citations breakdown →
10.
Vergote, Ignace, Jacques Bonneterre, Beat Thürlimann, et al.. (2000). Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women. European Journal of Cancer. 36. 84–85. 17 indexed citations
11.
12.
Chen, Weiyi, Tomáš Ruml, & Mark L. Steinberg. (1995). Characterization of a 1.8-kb DNA segment located upstream from the human Ha-ras protooncogene and possibly regulating its function. Gene. 155(2). 253–256. 1 indexed citations
13.
Staiano‐Coico, Lisa, Mark L. Steinberg, & Paul J. Higgins. (1990). Epidermal cell‐shape regulation and subpopulation kinetics during butyrate‐induced terminal maturation of normal and SV40‐transformed human keratinocytes: Epithelial models of differentiation therapy. International Journal of Cancer. 46(4). 733–738. 17 indexed citations
14.
Okada, N., Sachiko Miyagawa, Y. Horiguchi, et al.. (1989). Synthesis of epidermolysis bullosa acquisita antigen by simian virus 40-transformed human keratinocytes. Archives of Dermatological Research. 281(1). 1–4. 6 indexed citations
15.
Morris, Arvia E., et al.. (1989). Isolation of novel cDNA transformation markers from SV40-transformed human keratinocytes. Experimental Cell Research. 182(2). 461–472. 3 indexed citations
16.
Miyagawa, Sachiko, Natsuko Okada, Yoshinari Takasaki, et al.. (1989). Expression of Proliferating Cell Nuclear Antigen/Cyclin in Human Keratinocytes. Journal of Investigative Dermatology. 93(5). 678–680. 35 indexed citations
17.
Steinberg, Mark L., et al.. (1989). Specific high frequency rearrangements induced by MNNG in SV4O-infected human keratinocytes. Carcinogenesis. 10(10). 1801–1807. 6 indexed citations
18.
Miyagawa, Sachiko, Natsuko Okada, Yukio Kitano, et al.. (1988). SSA/Ro Antigen Expression in Simian Virus 40-Transformed Human Keratinocytes. Journal of Investigative Dermatology. 90(3). 342–345. 17 indexed citations
19.
Baden, Howard P., Joseph Kubilus, Sandra R. Wolman, et al.. (1987). NM1 Keratinocyte Line Is Cytogenetically and Biologically Stable and Exhibits a Unique Structural Protein. Journal of Investigative Dermatology. 89(6). 574–579. 18 indexed citations
20.
Steinberg, Mark L., et al.. (1984). Simple epithelial nature of some simian virus-40-transformed human epidermal keratinocytes.. PubMed. 44(12 Pt 1). 5797–804. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Björn Erikstein Breakdown of academic impact, for papers by Pascal Pujol Breakdown of academic impact, for papers by Cezary Cybulski Breakdown of academic impact, for papers by Laura P. Stabile Breakdown of academic impact, for papers by S. M. Lippman Breakdown of academic impact, for papers by Isaiah W. Dimery Breakdown of academic impact, for papers by Haruo Sugano Breakdown of academic impact, for papers by Marsha L. Frazier Breakdown of academic impact, for papers by Frej Stenbäck Breakdown of academic impact, for papers by Regina S. Whitaker
Rankless by CCL
2026